These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 132138)

  • 41. [An experimental evaluation of the acute and chronic oral toxicity of the antibiotic Bactericin for plant protection].
    Antov G; Zaĭkov Kh; Khalkova Zh; Mikhaĭlova A; Shumkov N
    Probl Khig; 1992; 17():109-16. PubMed ID: 1364530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of polyvinypyrrolidone on the antineoplastic and toxic properties of some antiblastomatous preparations].
    Kochetkova VA
    Farmakol Toksikol; 1967; 30(6):740-5. PubMed ID: 4175252
    [No Abstract]   [Full Text] [Related]  

  • 43. Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.
    Tevyashova AN; Olsufyeva EN; Balzarini J; Shtil AA; Dezhenkova LG; Bukhman VM; Zbarsky VB; Preobrazhenskaya MN
    J Antibiot (Tokyo); 2009 Jan; 62(1):37-41. PubMed ID: 19132061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of the toxic action of methacrylonitrile].
    Kurzaliev SA
    Gig Tr Prof Zabol; 1985 May; (5):37-40. PubMed ID: 4029691
    [No Abstract]   [Full Text] [Related]  

  • 45. [Toxicity and radioprotective properties of 3,4,5,6-tetrahydropyrimidine and 3,6-dihydropyrimidine derivatives].
    Il'iuchenko TIu; Frigidova LM; Shadurskiĭ KS; Lepekhin VP; Ignatova LA
    Farmakol Toksikol; 1980; 43(1):103-7. PubMed ID: 7379985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on antitumor antibiotic 1588--IV. Metabolism and toxicity studies].
    Yang GZ
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):5-7. PubMed ID: 6189686
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative evaluation of toxicity and antitumor activity of original and reproduced anthracycline drugs.
    Kuśnierczyk H; Radzikowski C; Górecki P; Cichocka K
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):51-62. PubMed ID: 7503636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.
    Zou Y; Priebe W; Stephens LC; Perez-Soler R
    Clin Cancer Res; 1995 Nov; 1(11):1369-74. PubMed ID: 9815933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Protein-nitrogen metabolism in the liver of rats intraperitoneally administered carminomycin].
    Vetoshkina TV; Gol'dberg ED; Sal'nik BIu; Bakhareva GI
    Antibiotiki; 1979 Feb; 24(2):127-33. PubMed ID: 434802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of lysosubtilin per os in mice, rabbits and calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(4):385-95. PubMed ID: 9257446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
    Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
    Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antitumor activity of carminomycin antibiotic used orally].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of olivomycin and bruneomycin and their combined use with prodigiozan on some nonspecific defense reactions of the host organism of transplanted lymphadenosis NK-LI].
    Shapovalova SP
    Antibiotiki; 1970 Oct; 15(10):924-8. PubMed ID: 4924376
    [No Abstract]   [Full Text] [Related]  

  • 54. [Studies on the toxicity and pharmacological properties of beromycin, a new antitumor antibiotic].
    Gol'dberg LE; Filippos'iants ST; Stepanova ES
    Antibiotiki; 1972 Jul; 17(7):616-23. PubMed ID: 4632010
    [No Abstract]   [Full Text] [Related]  

  • 55. [General toxic and organotropic side-effects of cephalothin in acute and chronic experiments].
    Berezhinskaia VV; Solov'ev VN; Berezina EK; Dolgova GV; Kovalenko LP
    Antibiotiki; 1981 Jan; 26(1):44-50. PubMed ID: 7212682
    [No Abstract]   [Full Text] [Related]  

  • 56. Differential toxicity of sulfur mustard administered through percutaneous, subcutaneous, and oral routes.
    Vijayaraghavan R; Kulkarni A; Pant SC; Kumar P; Rao PV; Gupta N; Gautam A; Ganesan K
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):180-8. PubMed ID: 15629193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of the diuretic diacarb on the antitumor activity of the antibiotics rubomycin and olivomycin].
    Stepanova ES
    Antibiotiki; 1975 Apr; 20(4):300-3. PubMed ID: 1243242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of the antibiotic variamycin on the growth of a rabbit brain tumor].
    Kondakov LI; Khalanskiĭ AS; Terent'eva TG; Iablonovskaia LIa
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):620-4. PubMed ID: 2945512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative experimental antitumor activity of the antibiotics variamycin and mitramycin].
    Terent'eva TG; Sokolov AB; Navashin SM
    Antibiotiki; 1978 Apr; 23(4):349-51. PubMed ID: 148238
    [No Abstract]   [Full Text] [Related]  

  • 60. [Production of a murine lymphadenosis NK/LY resistant to rubomycin and a comparison of the cellular DNA histograms of the sensitive and resistant lines].
    Prokhorova EV; Merkulova IB; Shelaputina ZF
    Antibiotiki; 1980 May; 25(5):370-4. PubMed ID: 7387132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.